RNF43 mutations were strongly associated with improved overall survival in the colorectal and bladder cancer cohorts (Fig. 4C, D), surpassing the relationship between survival and total mutational burden in these patients (Fig. S1A). This evidence concerns the gene RNF43 and urinary bladder cancer.